TB-500 (Thymosin β4 fragment)

TB-500 Storage, Stability and Reconstitution

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

TB-500 is supplied lyophilised and is most stable dry, cold and dark. Its composition rules out the common chemical degradation routes, no disulfides, no methionine oxidation, no deamidation hotspot,leaving hydrolysis and, more practically, physical adsorption to container surfaces.

Key facts

Supplied as
White lyophilised powder
Disulfide risk
None (no cysteine)
Oxidation risk
Low (no methionine)
Deamidation
No asparagine
Main chemical route
Hydrolysis
Main practical loss
Adsorption to surfaces
Freeze-thaw
Avoid by aliquoting

Why the usual advice mostly does not apply

Most peptide storage guidance is written around cysteine and methionine, disulfide scrambling and thioether oxidation. TB-500 has neither, and no asparagine either, so deamidation at the classic hotspot is also absent. As a chemical entity it is unusually forgiving, and the standard emphasis on protecting from oxidation is largely beside the point here.

What actually degrades it

Hydrolysis of the peptide backbone, which water enables and which is why the lyophilised form is the stable one. Freeze-drying removes the participant in that reaction, and cold storage slows what remains. Seven residues means few bonds to hydrolyse, so even this is slow relative to a larger peptide.

Research material referenced

TB-500 5mg, third-party HPLC tested

Buy TB-500 · £23.99

The loss mechanism that matters more

Adsorption. A small, strongly charged peptide binds to glass and plastic, and at low working concentrations the fraction lost to the vial and pipette tips can be a substantial share of the material. This is a physical loss with no chemical signature. The peptide that remains is intact, there is simply less of it than the calculation assumed. Low-binding consumables and minimising transfers are the practical responses.

Reconstitution

Introduce diluent gently down the vial wall rather than onto the powder, and swirl rather than shake. Foaming indicates an air-liquid interface has been created, and peptides unfold at that interface before aggregating. TB-500 dissolves readily given its charge and hydrophilicity, so vigorous agitation is never necessary.

After reconstitution

Aliquot into single-use volumes. Repeated freeze-thaw cycling concentrates solutes at the advancing ice boundary and creates fresh interfaces each cycle. Damage that the absence of oxidation-prone residues does nothing to prevent. Chemical robustness is not the same as physical robustness.

A note if the material is the full protein

If a vial actually contains full-length thymosin beta-4 rather than the heptapeptide, this guidance is incomplete: the 43-residue protein has a different composition, including methionine, and correspondingly different vulnerabilities. Establishing which compound is present is a prerequisite to handling it correctly.

Frequently asked questions

Does TB-500 need protecting from light?

Less than most peptides. There is no methionine to oxidise and no aromatic residue to photodegrade. Dark storage remains sensible but the specific liability is absent.

Why might I recover less than expected?

Adsorption to glass and plastic. A small, highly charged peptide binds surfaces, and at low concentrations that loss is significant.

Does it need a reducing agent?

No. There is no cysteine in the sequence.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More TB-500 (Thymosin β4 fragment) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.